Avid Bioservices to Participate at Upcoming Investor Conferences
Avid Bioservices to Participate at Upcoming Investor Conferences
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate at two upcoming investor conferences. Nick Green, president and chief executive officer, will be the featured speaker in a fireside chat at the RBC Capital Markets 2024 Global Healthcare Conference, and will deliver a corporate presentation at the 2024 Bank of America Securities Healthcare Conference.
加利福尼亞州塔斯汀，2024年5月7日（GLOBE NEWSWIRE）——Avid Bioservices, Inc.（納斯達克股票代碼：CDMO）是一家致力於通過向生物技術和製藥公司提供高質量的開發和製造服務來改善患者生活的專門生物製劑合同開發和製造組織（CDMO）今天宣佈，該公司將參加即將舉行的兩次投資者會議。總裁兼首席執行官尼克·格林將在加拿大皇家銀行資本市場2024年全球醫療保健大會的爐邊談話中擔任特邀發言人，並將在2024年美國銀行證券醫療保健會議上發表公司演講。
Details of the company's participation are as follows:
該公司的參與詳情如下：
-
RBC Capital Markets 2024 Global Healthcare Conference
Conference Date: May 14-15, 2024
Fireside Chat Time/Date: 4:35 – 5:05 p.m. Eastern on Tuesday, May 14, 2024
Location: InterContinental New York Barclay, New York
- 加拿大皇家銀行資本市場2024年全球醫療保健會議
會議日期：2024 年 5 月 14 日至 15 日
爐邊聊天時間/日期：2024 年 5 月 14 日星期二美國東部時間下午 4:35 — 5:05
地點：紐約巴克萊洲際酒店
-
2024 Bank of America Healthcare Conference
Conference Date: May 14-16, 2024
Presentation Time/Date: 11:55 a.m. – 12:10 p.m. Eastern on Thursday, May 16, 2024
Location: Encore Hotel, Las Vegas, NV
- 2024 年美國銀行醫療保健會議
會議日期：2024 年 5 月 14 日至 16 日
演講時間/日期：2024 年 5 月 16 日星期四美國東部時間上午 11:55 至下午 12:10
地點：內華達州拉斯維加斯安可酒店
About Avid Bioservices, Inc.
Avid Bioservices, Inc. 簡介
Avid Bioservices (NASDAQ: CDMO) is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With more than 30 years of experience producing biologics, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization.
Avid Bioservices（納斯達克股票代碼：CDMO）是一家專門的合同開發和製造組織（CDMO），專注於生物製劑的開發和CGMP製造。該公司爲生物技術和生物製藥行業提供全面的工藝開發、CGMP臨床和商業製造服務。Avid 擁有 30 多年的生物製劑生產經驗，其服務包括 CGMP 臨床和商用藥物製造、批量包裝、發佈和穩定性測試以及監管申報支持。對於早期項目，該公司提供各種工藝開發活動，包括細胞系開發、上下游開發和優化、分析方法開發、測試和表徵。我們的服務範圍從獨立的工藝開發項目到通過商業化的全面開發和製造計劃不等。
CONTACT: Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) Vida Strategic Partners 415-675-7402 tbrons@vidasp.com
聯繫人：聯繫人：斯蒂芬妮·迪亞茲（投資者）Vida 戰略合作伙伴 415-675-7401 sdiaz@vidasp.com 蒂姆·布朗斯（媒體）Vida 戰略合作伙伴 415-675-7402 tbrons@vidasp.com
譯文內容由第三人軟體翻譯。